Related Experiment Videos

Pediatric medication errors in the postanesthesia care unit: analysis of MEDMARX data

Christopher H Payne1, Christopher R Smith, Laura E Newkirk

  • 1Medical Wing, Wilford Hall Medical Center, Lackland AFB, Tex., USA.

AORN Journal
|April 10, 2007
PubMed

Insights

Medication errors in pediatric postanesthesia care are frequent and harmful. Analyzing medication errors in pediatric patients can help mitigate future risks.

Area of Science:

  • Anesthesiology
  • Pediatric Patient Safety
  • Medication Error Analysis

Background:

  • Medication errors in pediatric postanesthesia care units (PACUs) are a significant concern.
  • These errors occur in approximately 1 in 20 medication orders and pose a higher risk of harm compared to the general population.

Purpose of the Study:

  • To compare the incidence and characteristics of medication errors in pediatric patients within the PACU to those in the overall patient population.
  • To identify specific causes and products involved in pediatric medication errors.

Main Methods:

  • Analysis of six years of data from the MEDMARX database.
  • Utilized consecutive nonprobability sampling and descriptive statistics for data comparison.

Main Results:

  • Nineteen distinct causes of medication errors were identified.
  • Twenty-eight different products were implicated in these errors.
  • Pediatric PACU medication errors demonstrated unique patterns compared to the general population.

Conclusions:

  • Understanding the specific causes and products associated with pediatric medication errors is crucial.
  • Organizations can implement targeted strategies focusing on identified error causes and products to reduce future medication errors in pediatric PACUs.

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...